학술논문
Abstract 308
Document Type
Article
Author
Source
Circulation: Cardiovascular Quality & Outcomes; July 2014, Vol. 7 Issue: 1, Number 1 Supplement 1 pA308-A308, 1p
Subject
Language
ISSN
19417713; 19417705
Abstract
Background:Studies suggest HIV infected (HIV) people have similar rates of major adverse cardiovascular events (MACE) after AMI andor after percutaneous coronary interventions (PCI) compared to uninfected (HIV-) people. However, these studies were limited by a lack of CD4 cell count andor stent type data. Low CD4 cell count and bare metal stents (BMS) are associated with higher MACE rates than high CD4 cell count and drug eluding stents (DES), respectively. Our study compared the rates and risk of MACE and mortality after PCI between HIV and HIV- stratified by stent type and CD4 cell count.